Atorvastatin
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include diarrhea, arthralgia, myalgia, urinary tract infectious disease, nasopharyngitis, pain, in extremity.
Category
Category
HMG-COA Reductase Inhibitor
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH